Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback